Greatness doesn't get days off.

As a leader in equine health, Boehringer Ingelheim is committed to innovation and development. With our expanded portfolio offerings, we aren't just talking the talk. See for yourself. 

Click on the logos below for more info.

Boehringer Ingelheim Equine Headlines Wins Prestigious Media Award
Equine publication professionals recognized the BIVI IDPPID website at the 2016 annual American Horse Publications Media Awards as best in the equine-related website class. The site is designed to help both horse owners and veterinarians easily identify the signs of Pituitary Pars Intermedia Dysfunction, formerly known as equine Cushing’s disease. Visit the site at, and see how BIVI is helping shape the future of equine health.

Have you seen the signs of PPID?
The early clinical signs of Pituitary Pars Intermedia Dysfuntion (PPID), also known as equine Cushing’s disease, can be subtle. Take advantage of our testing offer this spring. Veterinarians can request up to 3 free tests from Boehringer Ingelheim for horses suspected to have PPID.

2016 Equine Research Award Recipients Announced
The awards were announced at the 2016 American Association of Equine Practitioners Annual Convention in Las Vegas. Each researcher received a grant of $15,000 in support of their study proposal.

Second Veterinary Technician Champion of the Cause Award Winner Selected
The second Champion of the Cause Award winner, Claudia Cary Davidson, is an equine veterinary technician at Fowlerville Veterinary Clinic in Fowlerville, Michigan. Davidson was nominated by Dean Gibbons, DVM.

Cases more common in even well-vaccinated horses
Data from research on recent equine influenza virus (EIV) outbreaks show a noticeable change in the horses being affected by the virus.

Reducing equine respiratory virus spread
Reducing the spread of equine respiratory viruses is key to equine health; however, some of these viruses can be difficult to eliminate and some can lead to explosive outbreaks.

Timeline of products

How our products help horses
achieve their potential


PRASCEND is the first and only medicine available in the United States that is approved by the FDA for the control of clinical signs associated with pituitary pars intermedia dysfunction (PPID), historically termed “equine Cushing’s disease,” in horses.

Important Safety Information

PRASCEND has not been evaluated in breeding, pregnant, or lactating horses and may interfere with reproductive hormones in these horses. See complete prescribing information.


Following the recommendation of the Expert Survellence Panel on Equine Influenza, VETERA vaccines contain updated flu strains. Following these recommendations can help protect from flu strains most likely to infect horses today.